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ABSTRACT 
 Poor water properties, use of concentrated bicarbonate, and biofilm growth in pipes 
and storage tanks often cause dialysis water and dialysate contamination with bacteria and 
endotoxins. High-flux dialysis with bicarbonate may favour endotoxin transfer from the 
dialysate into the blood exposing patients to serious short and long term side effects. 
Ultrafiltration across hydrophobic synthetic membranes effectively remove endotoxins 
from dialysis water by combined filtration and adsorption. However, repeated sterilization 
worsens the membrane separation properties, and limits their use. Ceramic membranes are 
generally more resistant to harsh operating conditions than polymeric membranes, and may 
represent an alternative for endotoxin removal. Previously, we proved that the ceramic 
membranes commercially available at that time were not retentive enough to ensure 
production of endotoxin-free dialysis water. 
 In this paper, we investigated the endotoxin removal capacity of new generation 
commercial ceramic membranes with nominal molecular weight cut-off down to 1,000. In 
dead-end filtration, all investigated membranes produced water meeting, or close to, the 
European standards when challenged with low endotoxin concentrations, but only one 
membrane type succeeded at high endotoxin concentrations. In cross-flow filtration, none 
produced water meeting the European standard. Moreover, sterilization and rinsing 
procedures altered the separation properties of two out of three membrane types. 
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INTRODUCTION 
 At the beginning of the 90’s, investigations in dialysis centers have revealed that a 
large fraction of the centers tested were using dialysis water and dialysate strongly 
contaminated with bacteria and endotoxins [1-4]. Klein et al. [1,2] reported that 53% of 51 
centers investigated in the USA used dialysis water exhibiting bacterial count exceeding 
200 CFU/ml. 35% of the centers used also dialysate with bacterial counts higher than 2000 
CFU/ml. In 12% of the centers, endotoxin level in the dialysate was also above 5 EU/ml 
(i.e., endotoxin units per ml). In Germany, a similar survey in 30 dialysis centers revealed 
that 40% of the centers used dialysis water with bacterial count higher than 200 CFU/ml, 
and that 43% of the centers used dialysate with bacterial count exceeding 2000 CFU/ml. 
Endotoxin levels in dialysis water and dialysate were found to be higher than 5 EU/ml in 
22% and 50% of all centers, respectively [3].  
 Microbial contamination of dialysis water and dialysate is acknowledged to be the 
cause of life-threatening acute and invalidating chronic side effects in patients undergoing 
hemodialysis [4]. To minimize the occurrence of such effects, national authorities have 
issued rules setting the maximum tolerable concentrations of bacteria and endotoxins in 
dialysis water and dialysate. The European Pharmacopoeia sets the maximal values of 
bacterial count and endotoxin concentration in the water used to prepare the dialysate at 
100 CFU/ml and 0.25 EU/ml, respectively [5]. The American Association for the 
Advancement of Medical Instrumentation (AAMI) accepts higher bacterial counts in 
dialysis water with a limit of 200 CFU/ml [6]. However, the AAMI prescribes that bacterial 
count in the dialysate should not exceed 2000 CFU/ml, whereas the European 
Pharmacopoeia does not provide any limit for it. Neither authority sets limits for endotoxin 
concentration in the dialysate. In spite of experimental evidences, and the rules set by 
national authorities, dialysis centers are slowly including processes for endotoxin removal 
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in their water treatment plants on the assumption that the separation properties of dialysis 
membranes make them a safe enough barrier against endotoxins. It is now commonly 
agreed that endotoxins and their fragments do cross dialysis membranes irrespective of 
whether they are low or high flux [7]. Therefore, use of highly purified dialysate (i.e., 
concentration of bacteria < 100 CFU/ml, and endotoxins < 0.25 EU/ml) may be expected to 
improve the biocompatibility of the whole haemodialysis treatment.  
 The main contributors to microbial contamination have been proven to be the water 
used for preparing the dialysate, the bicarbonate concentrate, and the dead spaces in the 
fluid distribution system where a biofilm may develop [4]. Pre-treatment with filters, 
softeners, active carbon cartridges, microfilters, followed by treatment by reverse osmosis 
and/or de-ionization generally yields dialysis water meeting the official requirements. Prior 
to preparing the dialysate, water is generally filtered across sub-micron filters, and then 
treated with ultraviolet radiation [4]. The former remove whole bacteria but cannot clear 
endotoxins and their fragments. Ultraviolet radiations disinfect the water by killing bacteria 
but, by doing so, contaminate the water with bacterial wall fragments (i.e., endotoxins).  
Endotoxin removal from the dialysate is best achieved by on-line ultrafiltration through 
thick hydrophobic membranes (e.g., made of polysulphone or polyamide) that reject and 
adsorb large amounts of endotoxins [8-10]. Several studies clearly show the effectiveness 
of ultrafiltering the dialysate through endotoxin-adsorbing membranes just before it enters 
the hemodialyer [11,12]. However, the polymeric membranes used exhibit poor separation 
properties after repeated disinfection cycles, which limits the time they can be used. 
Ceramic membranes for ultra-/nanofiltration could be a convenient alternative to adsorptive 
filtration across polymeric membranes. In fact, they generally withstand the harsh 
conditions at which membranes are disinfected and heat sterilized better than polymeric 
membranes. Thus, they could be repeatedly used for quite a long time. In a previous 
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investigation, we showed that the ceramic nanofiltration membranes commercially 
available at that time did not effectively remove endotoxins from aqueous solutions [13,14].  
 In this paper, we report our investigation aimed at analyzing the endotoxin removal of 
new commercial ceramic membranes for ultra-/nanofiltration from aqueous solutions when 
they are operated either in cross-flow, or dead-end mode.  
 
MATERIALS AND METHODS 
 We investigated three types of commercial tubular ceramic membranes for ultra- and 
nanofiltration, whose nominal properties are reported in Table 1. They were assembled in 
modules that were installed in the experimental apparatus shown in Figure 1, and were 
challenged with aqueous solutions spiked with endotoxins fed to the membrane lumen. 
Patent membranes were tested in the cross-flow mode, at 3 m/s tangential velocity, 25°C, 
1.5 bar transmembrane pressure for 60 min. In an effort to simulate the worst possible 
conditions under which membranes might actually remove endotoxins, the test solutions 
were also filtered across the membranes in dead-end, single-pass mode for 40 min, at 25°C, 
1.5 bar transmembrane pressure. Experiments where membranes were challenged with 
endotoxins for 5 h were performed after the membranes had undergone at least four 
complete sterilization and rinsing cycles. In each cycle, the membranes were sterilized at 
180º degrees Celsius in a hot air sterilizer (SL600, Memmert, Schwabach, Germany), 
rinsed with 1 M NaOH and 60% ethanol, and rinsed again with highly purified pyrogen-
free water [15].  The whole test equipment was subjected to the same rinsing procedure. 
Two membrane modules of each type were tested at given endotoxin concentration, and 
operating conditions. Change of the permeate flux at the given transmembrane pressure was 
used as an indicator of the occurrence of fouling, or of damages to the membrane selective 
“skin” layer.  
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 Membranes were challenged with endotoxin-containing solutions at concentrations 
ranging from 0 to 2000 EU/ml. Endotoxins from E. coli were used throughout (E. coli 
Serotype 055 B5, Charles River, Kisslegg, Germany). Permeate samples were timely 
collected and assayed for endotoxins. Endotoxin concentration was measured with the 
kinetic turbidimetric Limulus Amoebocyte Lysate (LAL) Test (Charles River Endosafe, 
Kisslegg, Germany), with a micro titer plate reader (Sunrise, Tecan, Austria), and evaluated 
with the Endosafe software (Charles River Endosafe, Kisslegg, Germany). This method 
ensures sensitive detection of bacterial endotoxins, down to 0.125 EU/ml [16]. In this 
investigation, reference is made to the 0.25 EU/ml upper limit set for endotoxin 
concentration in dialysis water by the European Pharmacopoeia [5]. 
 Membranes were generally characterized after their use. Membrane morphology was 
analyzed by scanning electron microscopy, after coating with gold under vacuum. 
Membrane pore size distribution was investigated by mercury intrusion with a AutoPore IV 
9500 (Micromeritics Instrument Co., Norcross GA, USA) porosimeter. The membrane 
rejection coefficient spectrum was characterized by filtering a 0.8 g/l aqueous solution of 
polyethyleneglycols (PEGs) or Dextrans of different molecular weight (MW) (Sigma 
Aldrich, Steinheim, Germany) across the membranes in dead-end mode for 1.5 h at 20 l/m2 
h. Concentration of a given molecular weight solute in permeate, feed and retentate was 
estimated by GPC using a MZ Hema Bio column (MZ Analytik, Mainz, Germany) coupled 
to a refractive index detector (Waters, Milford MA, USA), with reference to PEG 
calibration standards. The rejection coefficient was estimated as R = 1 - (2 Cpermeate / 
(Cretentate + Cfeed )). The molecular weight cut-off was estimated as the molecular weight of a 
solute rejected by the membrane to an extent equal to 90%. 
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RESULTS 
 Figures 2 a-f show that all investigated membranes exhibit a rather thick and 
asymmetric wall with an inner skin layer, supported by a porous layer of granular ceramics. 
The region in the supporting layer closer to the skin is generally made of granules of 
smaller size and has a lower porosity than that farther away. In membranes type #3, the 
granules in the supporting layer is flaky and less orderly distributed than that in the other 
membranes generally causing a lower porosity and the occasional formation of larger-than-
average pores as shown in Figures 2 d-f. Mercury intrusion evidenced only the presence of 
pores in the range from 10 to 0.1 microns, presumably in the supporting layers. In fact, the 
thicker walls and the smaller porosity than those of organic membranes might make it 
difficult for intrusion techniques to detect pores in the skin layer of ceramic membranes.   
 Table 2 shows the endotoxin concentrations detected in the permeate of different 
patent ceramic membranes after 40-60 min from spiking water with the endotoxin bolus. 
When membranes #1 and #2 were operated in the cross-flow filtration mode and challenged 
with 1000 EU/ml endotoxins, neither of them produced water meeting the 0.25 EU/ml 
limit. In fact, endotoxin concentration in the permeated water was consistently higher than 
0.5 EU/ml although lower than 5 EU/ml. Table 2 shows that, when operated in dead-end 
mode and challenged with low endotoxin concentrations, type #2 and #3 membranes 
yielded permeate water containing approximately 0.25 EU/ml endotoxins. Only type #1 
membranes produced water meeting the European standards. When the endotoxin challenge 
was increased by an order of magnitude, only the most permeable membranes type #1 
unexpectedly produced water with by far less than 0.25 EU/ml endotoxins.  
 After at least 4 complete sterilization and rinsing cycles, membranes type #2 and #3 
exhibited altered water permeability. In fact, the permeate flux through type #2 membranes 
decreased to 280 ml/(min m2) from the 1330 ml/(min m2) value for the patent membranes. 
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The permeate flux through membranes type #3 dramatically increased to 5270 ml/(min m2) 
from the 947 ml/(min m2) value for the patent membranes. Type #1 membranes 
consistently yielded a permeate flux of 9500 ml/(min m2). After 1.5 h dead-end filtration of 
a 100 EU/ml endotoxin challenge, all these membranes yielded permeate water with less 
than 0.25 EU/ml. It is noteworthy that membranes type #1 produced water with less than 
0.05 EU/ml endotoxin. After 5 h dead-end filtration, endotoxin concentration in the 
permeate of membranes type #2 and #3 was less than 1.5 EU/ml and ca. 0.5 EU/ml 
respectively, and was less than 0.05 EU/ml in the permeate of membranes type #1. When 
challenged with 1000 EU/ml endotoxins, none of the tested membranes produced water 
meeting the 0.25 EU/ml requirement. In particular, endotoxin concentration in the permeate 
of membranes type #2 and #3 exceeded 5 EU/ml, and was generally less than 0.5 EU/ml in 
the permeate of membranes type #1. The tested membranes generally exhibited a rather 
slanted rejection spectrum after sterilization. Figure 3 shows that the membranes type #3 
exhibited also a 19.500 Da molecular weight cut-off, largely exceeding their nominal 1.000 
Da value. 
 
DISCUSSION AND CONCLUSIONS 
 Endotoxins are cell wall components of gram-negative bacteria whose molecular 
weight is reported to range from 2000 to more than 100,000 [4]. The nominal molecular 
weight cut-off of the membranes used in this investigation (see Table 1) suggests that 
filtration of endotoxin-containing water across these membranes would yield sterile and 
endotoxin-free water meeting the strict European standards. Our results show that, when 
challenged with 100 EU/ml endotoxin in dead-end mode, the tested patent membranes 
produced water close to the 0.25 EU/ml requirement in the permeate. In particular, the 
membranes type #1 consistently produced permeated water with less than 0.05 EU/ml also 
New ceramic membranes for endotoxin removal 10
when challenged with high endotoxin concentrations. Comparison with the performance of 
the membranes tested in our previous investigations [13,14] clearly shows the great 
improvement in the manufacturing techniques of commercial ceramic membranes now 
delivering the expected performance in vitro. 
 The poor endotoxin retention of patent membranes type #1 and #2 when operated in 
cross-flow filtration mode suggests that the accumulation of rejected endotoxins upstream 
from the membrane plays an important role in determining the actual membrane rejection 
towards endotoxins. In fact, in dead-end filtration mode, endotoxins would concentrate at 
the membrane wall and might get trapped in the membrane pores as an effect of the poor 
solute back transport. At low endotoxin concentrations in the bulk, the trapped endotoxins 
would hinder permeation of the free molecules resulting in increased membrane rejection 
towards endotoxins. At high endotoxin concentrations in the bulk, the accumulated 
endotoxin overload would cause concentration polarization that decreases the observed 
membrane rejection towards endotoxins, as it was observed experimentally. Any 
enhancement of endotoxin back transport would decrease membrane rejection and would 
increase endotoxin concentration in the permeate, as it was observed in the cross-flow 
filtration experiments. Endotoxin adsorption at the membrane pore surface may be also 
evoked to explain the good endotoxin rejection of membranes type #1 in spite of their high 
permeability and large mean pore size. In fact, Figures 2d-f suggest that these membranes 
have a rather high specific contact area at least when compared to membranes type #3. 
Lack of information on the actual properties of the ceramics used prevents speculation on 
the existence of specific chemical interactions between endotoxins and membrane material. 
 The inconsistent performance of membranes type #2 and #3 before and after they 
underwent at least four complete sterilization and rinsing cycles brings up an unexpected 
limit to the tested membranes. In fact, the significant change of membrane permeability to 
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water suggests that repeated sterilization and rinsing might have seriously damaged or 
altered the membrane separation layer. Figure 3 confirms that this is indeed the case for the 
type #3 membranes whose molecular weight cut-off increased ca. twenty fold over the 
nominal value, consistent to the change of water permeation flux. Good news is that at least 
membranes type #1 successfully withstood repeated cleaning and sterilization procedures 
and consistently produced permeated water of good purity. 
 We conclude that some commercially available ultra-/nanofiltration ceramic 
membranes have the potential of removing endotoxins from dialysis water. However, poor 
endotoxin rejection in cross-flow filtration and in long-term dead-end mode hinders their 
use in routine hemodialysis at this time. Better understanding of the mechanisms leading to 
endotoxin removal, further improvement in membrane actual rejection properties and 
chemical stability should still be pursued to exploit some of their advantageous 
characteristics in the near future. 
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Membrane Identity Membrane #1 Membrane #2 Membrane #3 
Geometry Single channel Single channel Multiple channels 
Number of channels 1 1 3 
Material Al2O3/TiO2/ZrO2 Al2O3/TiO2/ZrO2 Al2O3/TiO2/ZrO2 
Length 250 mm 250 mm 250 mm 
Nominal MW Cut-
Off, NMWCO 20 nm
1,2 5 kD1 1 kD1 
  
Table 1.  Properties of the ceramic membranes used in this investigation: 










Operating Endotoxin challenge Membrane #1 Membrane #2 Membrane #3 
mode EU/ml     20 nm 5 kD 1 kD 
Cross-flow 0 0* 0* NA 
Filtration 1000 <5* <5* NA 
  0 0 0 0 
Dead-end 100 <0,05 ≤0,25 ≤0,25 
Filtration 1000 <0,05 <0,5 NA 
  2000 NA NA <0,5 
 
Table 2. Endotoxin concentration, EU/ml, in the permeate water across patent  
 ceramic membranes after 40-60* min from the endotoxin challenge:  
 NA: not available. 
 




Figure 1.  Schematic of the experimental apparatus: BPV - back pressure valve;  
 DV - discharge valve; M - manometers; MM - test membrane module;  
 MU - muffler; P - pump; PD - pulse dampener; R - reservoir;  
 T - thermometer; V – valve. 
 
Figure 2. SEMs of the the investigated membranes.  
 Cross-section of: a - membranes type #1; b – membranes type #2;  
 c – membranes type #3. 
 Magnification of the wall of : d - membranes type #1;  
 e – membranes type #2; f – membranes type #3. 
 
Figure 3. Rejection coefficient vs. molecular weight curve for type #3 membranes after  
 sterilization. Membranes tested with an aqueous solution of PEGs of different  
 molecular weight. See Materials and Methods for details. 
